219 related articles for article (PubMed ID: 26995142)
1. Optimization and validation of an existing, surgical and robust dry eye rat model for the evaluation of therapeutic compounds.
Joossen C; Lanckacker E; Zakaria N; Koppen C; Joossens J; Cools N; De Meester I; Lambeir AM; Delputte P; Maes L; Cos P
Exp Eye Res; 2016 May; 146():172-178. PubMed ID: 26995142
[TBL] [Abstract][Full Text] [Related]
2. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
3. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
5. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.
Zhu L; Shen J; Zhang C; Park CY; Kohanim S; Yew M; Parker JS; Chuck RS
Mol Vis; 2009; 15():250-8. PubMed ID: 19190733
[TBL] [Abstract][Full Text] [Related]
7. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
9. Effects of silk fibroin in murine dry eye.
Kim CE; Lee JH; Yeon YK; Park CH; Yang J
Sci Rep; 2017 Mar; 7():44364. PubMed ID: 28281688
[TBL] [Abstract][Full Text] [Related]
10. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
Tabuchi N; Toshida H; Koike D; Odaka A; Suto C; Ohta T; Murakami A
J Ocul Pharmacol Ther; 2017; 33(1):24-33. PubMed ID: 28009531
[TBL] [Abstract][Full Text] [Related]
11. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.
Viau S; Maire MA; Pasquis B; Grégoire S; Fourgeux C; Acar N; Bretillon L; Creuzot-Garcher CP; Joffre C
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):857-67. PubMed ID: 18357464
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the Robustness of Distinct Clinical Assessments in Identifying Dry Eye Condition of Animal Models.
Hsieh HH; Chang YA; Chan S; Lin ZQ; Lin CT; Hu FR; Hung KF; Sun YC
Curr Eye Res; 2024 Jun; 49(6):565-573. PubMed ID: 38299568
[TBL] [Abstract][Full Text] [Related]
13. The Effect of the Aqueous Extract of Bidens Pilosa L. on Androgen Deficiency Dry Eye in Rats.
Zhang C; Li K; Yang Z; Wang Y; Si H
Cell Physiol Biochem; 2016; 39(1):266-77. PubMed ID: 27337217
[TBL] [Abstract][Full Text] [Related]
14. No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye.
Viau S; Pasquis B; Maire MA; Fourgeux C; Grégoire S; Acar N; Bretillon L; Creuzot-Garcher CP; Joffre C
Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):547-57. PubMed ID: 21161262
[TBL] [Abstract][Full Text] [Related]
15. Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
Chen Y; Zhang X; Yang L; Li M; Li B; Wang W; Sheng M
Mol Med Rep; 2014 May; 9(5):2015-23. PubMed ID: 24626526
[TBL] [Abstract][Full Text] [Related]
16. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.
Huang JF; Yafawi R; Zhang M; McDowell M; Rittenhouse KD; Sace F; Liew SH; Cooper SR; Pickering EH
Ophthalmology; 2012 Jul; 119(7):e43-50. PubMed ID: 22607938
[TBL] [Abstract][Full Text] [Related]
18. Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye.
Xiao B; Wang Y; Reinach PS; Ren Y; Li J; Hua S; Lu H; Chen W
PLoS One; 2015; 10(1):e0115333. PubMed ID: 25590134
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
Daull P; Barabino S; Feraille L; Kessal K; Docquier M; Parsadaniantz SM; Baudouin C; Garrigue JS
Curr Eye Res; 2019 May; 44(5):476-485. PubMed ID: 30664361
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
